Significant associations were observed between the XRCC1 Arg399Gln and breast cancer risk in both of the dominant and additive models (OR for dominant model = 1.12, 95% CI: 1.02–1.24; OR for additive model = 1.07, 95% CI: 1.01–1.14; Figure 2–3), but no association was found in recessive model (OR = 0.95, 95% CI: 0.84–1.08; Figure S1). This evidence concerns the gene XRCC1 and breast carcinoma.